Breaking Down Kunshan Kinglai Hygienic Materials Co.,Ltd. Financial Health: Key Insights for Investors

Spotlight on Kunshan Kinglai Hygienic Materials Co., Ltd. (300260.SZ): Q3 revenue jumped to 845.27 million CNY (a sequential rise of 13.72%) while TTM sales sit at 2.94 billion CNY with 2024 annual revenue of 2.85 billion CNY; profitability shows a 7.37% profit margin and 9.34% operating margin but faces headwinds - Q1 2025 net income dropped 25.56% year-over-year and EPS fell to 0.125 CNY, valuation metrics are rich (trailing P/E 61.50, forward P/E 28.81, P/S 6.94, P/B 6.50) while balance-sheet indicators show moderate leverage (debt/equity 85.88%), cash of 534.49 million CNY, current ratio 1.37 and interest coverage 5.2; growth levers include a 25% year-on-year lift in 2024 revenue driven by hygiene/medical products, a 33.33% jump in medical sales to 800 million CNY and a 40% rise in net profit to 200 million CNY in 2024, yet risks such as a 25% reduction in institutional holdings (March 2025) and high EV/EBITDA (35.51) warrant scrutiny - read on for detailed breakdowns, scenario analysis and what these numbers mean for investors.}

Kunshan Kinglai Hygienic Materials Co.,Ltd. (300260.SZ) Revenue Analysis

• Q3 2025 revenue: 845.27 million CNY (+13.72% QoQ)
• Prior quarter (approx.): 743.80 million CNY
• TTM revenue: 2.94 billion CNY (+1.58% YoY)
• 2024 annual revenue: 2.85 billion CNY (+5.08% YoY)
• Revenue per employee: ~1.07 million CNY (2,754 employees)
• Price-to-sales (P/S): 6.94
• Market capitalization: 20.43 billion CNY

Kunshan Kinglai Hygienic Materials Co.,Ltd. (300260.SZ) - Profitability Metrics

• Net margin: 7.37% - net income generation after all expenses and taxes.
• Operating margin: 9.34% - indicates effective control over operating costs relative to revenue.
• Gross profit margin: 24.9% - healthy spread above direct production costs.
• EBITDA margin: 10.7% - strong indicator of core operating profitability before non-cash and financing items.
• Return on assets (ROA): 3.62% - asset base delivering modest returns.
• Return on equity (ROE): 10.87% - equity holders receiving double-digit returns on invested capital.
• Q1 2025 net income attributable to shareholders: 50.99 million CNY - down 25.56% YoY.
• Q1 2025 EPS: 0.125 CNY (Q1 2024: 0.168 CNY) - reflects the drop in earnings per share.

• Margin structure: Gross margin at 24.9% provides a buffer for operating leverage, supporting the 9.34% operating margin and 10.7% EBITDA margin.
• Profitability vs. capital: ROE (10.87%) outpaces ROA (3.62%), suggesting leverage or higher returns on equity-financed operations.
• Short-term earnings pressure: Q1 2025 net income and EPS reductions (-25.56% YoY and EPS decline to 0.125 CNY) warrant monitoring of revenue trends, input costs, and non-recurring items.

Kunshan Kinglai Hygienic Materials Co.,Ltd. (300260.SZ) - Debt vs. Equity Structure

Key balance-sheet and market-valuation metrics frame how Kunshan Kinglai funds operations and how the market prices those activities. Below are the principal figures investors should weigh when assessing leverage, liquidity, tangible net worth, and enterprise valuation.

• Total debt-to-equity ratio: 85.88% - a moderate reliance on debt relative to shareholders' equity.
• Current ratio: 1.37 - short-term assets exceed short-term liabilities, indicating adequate working-capital coverage.
• Book value per share: 4.92 CNY - direct per-share measure of net asset value on the balance sheet.
• Enterprise value / Revenue: 5.13 - market-implied valuation per unit of revenue.
• Enterprise value / EBITDA: 35.51 - market valuation relative to operating cash profitability (EBITDA).
• Total cash position: 534.49 million CNY - a material liquidity buffer supporting operations and debt servicing.

Practical considerations for investors:

• With debt-to-equity near 86%, the company uses meaningful leverage while remaining below typical high-leverage thresholds (>100%).
• The current ratio of 1.37 suggests routine short-term coverage, but monitoring working-capital trends is advised.
• Book value per share (4.92 CNY) provides a conservative floor vs. market price; compare to share price to assess margin of safety.
• EV/Revenue of 5.13 and EV/EBITDA of 35.51 indicate the market assigns a premium to the company's revenue stream and operating earnings - investigate growth expectations and margin sustainability that justify these multiples.
• A cash stockpile of 534.49 million CNY enhances flexibility for capex, debt repayment, or strategic initiatives.

For broader context on the company's guiding principles and strategic orientation, see: Mission Statement, Vision, & Core Values (2026) of Kunshan Kinglai Hygienic Materials Co.,Ltd.

Kunshan Kinglai Hygienic Materials Co.,Ltd. (300260.SZ) - Liquidity and Solvency

• Current ratio: 1.37 - adequate coverage of current liabilities by current assets.
• Quick ratio (excl. inventory): ~1.05 - sufficient liquid assets when inventory is excluded.
• Cash ratio: 0.25 - cash and equivalents cover 25% of current liabilities, signaling moderate cash buffers.
• Interest coverage ratio: 5.2 - operating earnings cover interest expense by just over five times, reducing refinancing risk.
• Operating cash flow ratio: 1.1 - operating cash flow slightly exceeds current liabilities, reflecting positive operating liquidity.
• Free cash flow margin: 8.5% - efficient conversion of revenue into discretionary cash after capex.

• Implications for investors: the mix of ratios suggests a resilient operating cash profile with moderate reliance on working capital and a reasonable cushion against short-term stress.
• Risks to monitor: a cash ratio of 0.25 means cash is limited relative to current liabilities; capital structure changes or sudden revenue drops could pressure liquidity.
• Positive indicators: interest coverage >5 and free cash flow margin near 9% support debt-servicing capacity and potential for shareholder returns or reinvestment.

Kunshan Kinglai Hygienic Materials Co.,Ltd. (300260.SZ) - Valuation Analysis

This section breaks down market-implied valuations and relative multiples for Kunshan Kinglai Hygienic Materials Co.,Ltd. using current market metrics to help investors assess pricing versus earnings, sales and book value.

• Trailing P/E: 61.50 - implies a high multiple on historical earnings, signaling market expectations or recent profit weakness.
• Forward P/E: 28.81 - materially lower than trailing P/E, reflecting expected earnings growth or recovery embedded in consensus forecasts.
• P/S: 6.94 - the market values each yuan of sales at nearly seven times, indicating premium pricing relative to revenue.
• P/B: 6.50 - equity is trading at a significant premium to book value, suggesting intangible value, strong ROE expectations, or limited tangible asset base.
• EV/Revenue: 5.13 - enterprise value implies revenue is worth just over five times, useful for capital-structure-neutral comparisons.
• EV/EBITDA: 35.51 - a high multiple on operating cash flow proxy, pointing to stretched valuation versus typical industrial machinery peers.

Key valuation considerations for analysts and investors:

• Growth expectations: The wide gap between trailing and forward P/E suggests significant expected earnings acceleration; validate via revenue guidance and margin improvement trends.
• Profitability vs. valuation: EV/EBITDA of 35.51 signals elevated expectations for EBITDA growth or unusually low current EBITDA-investigate margin drivers, capacity utilization, and product mix.
• Balance sheet lean: P/B of 6.50 implies market rewards intangible assets, brand, or superior ROE; check returns on equity and asset turnover for sustainment.
• Revenue premium: P/S near 7x requires durable revenue growth or high-margin business lines to justify; analyze contract backlog, customer concentration, and pricing power.

For company context and strategic positioning, see: Mission Statement, Vision, & Core Values (2026) of Kunshan Kinglai Hygienic Materials Co.,Ltd.

Kunshan Kinglai Hygienic Materials Co.,Ltd. (300260.SZ) Risk Factors

Key financial and investor-confidence risks for Kunshan Kinglai Hygienic Materials Co.,Ltd. (300260.SZ) are highlighted below with recent Q1 2025 figures and related implications. For broader context on the company's background and business model see Kunshan Kinglai Hygienic Materials Co.,Ltd.: History, Ownership, Mission, How It Works & Makes Money.

• High valuation: trailing P/E ratio = 61.50 - elevated relative to typical industrial peers, increasing downside sensitivity to earnings misses.
• Profitability pressure: Q1 2025 net income down 25.56% YoY, signaling weakening bottom-line performance.
• Revenue stagnation: Q1 2025 revenue down 2.33% YoY and down 2.30% sequentially, indicating slowing sales momentum and possible seasonal or market headwinds.
• Operational challenges: net income after deducting non-recurring items decreased 14.60% YoY in Q1 2025, pointing to core business margin compression.
• Investor confidence: institutional holdings reduced by 25% (reported March 2025), which may reflect lowered institutional appetite or reallocation away from the stock.

• Potential market risks: cyclical demand for hygienic materials, raw-material cost volatility, and competitive pricing pressure could amplify earnings sensitivity given the current high valuation.
• Liquidity & sentiment risk: a 25% drop in institutional holdings can increase share-price volatility and reduce secondary-market liquidity in stressed conditions.
• Earnings execution risk: with core net income (-14.60% YoY ex-nonrecurring) and headline net income (-25.56% YoY) both negative, management faces execution risk to restore margin and growth.

Kunshan Kinglai Hygienic Materials Co.,Ltd. (300260.SZ) - Growth Opportunities

• Medical-grade nonwoven fabric sales: 800 million CNY in 2024 - a 25% YoY increase from 2023.
• Total medical sales rose from 600 million CNY in 2023 to 800 million CNY in 2024 - a 33.33% increase.
• Company-wide revenue growth in 2024: 25% YoY, driven by core hygiene and medical product lines.
• Net profit in 2024: 200 million CNY - a 40% YoY increase, signaling margin improvement and operational leverage.

• Demand drivers: sustained healthcare demand, increased procurement for medical disposables, and rising international shipments supported by quality certifications.
• Margin levers: scale in medical nonwovens, product mix shift to higher-margin medical items, and operational efficiencies reflected in 40% net profit growth.
• Strategic diversification: semiconductor components expansion can utilize existing process control, cleanroom practices, and supplier networks to accelerate entry and capture higher-value contracts.